BCAL Diagnostics Limited (ASX:BDX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0860
+0.0160 (22.86%)
Sep 17, 2026, 3:34 PM AEST

BCAL Diagnostics Statistics

Total Valuation

ASX:BDX has a market cap or net worth of AUD 25.81 million. The enterprise value is 31.14 million.

Market Cap25.81M
Enterprise Value 31.14M

Important Dates

The last earnings date was Thursday, September 3, 2026.

Earnings Date Sep 3, 2026
Ex-Dividend Date n/a

Share Statistics

ASX:BDX has 368.68 million shares outstanding. The number of shares has increased by 2.22% in one year.

Current Share Class 368.68M
Shares Outstanding 368.68M
Shares Change (YoY) +2.22%
Shares Change (QoQ) +0.79%
Owned by Insiders (%) 28.98%
Owned by Institutions (%) 6.35%
Float 179.11M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.97
PB Ratio -31.24
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 13.24
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.36

Current Ratio 1.36
Quick Ratio 1.32
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -1.04
Interest Coverage -20.39

Financial Efficiency

Return on equity (ROE) is -273.29% and return on invested capital (ROIC) is -60.16%.

Return on Equity (ROE) -273.29%
Return on Assets (ROA) -50.29%
Return on Invested Capital (ROIC) -60.16%
Return on Capital Employed (ROCE) -151.72%
Weighted Average Cost of Capital (WACC) 7.71%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.27
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +30.30% in the last 52 weeks. The beta is 0.81, so ASX:BDX's price volatility has been lower than the market average.

Beta (5Y) 0.81
52-Week Price Change +30.30%
50-Day Moving Average 0.07
200-Day Moving Average 0.09
Relative Strength Index (RSI) 67.51
Average Volume (20 Days) 117,597

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ASX:BDX had revenue of AUD 2.35 million and -7.37 million in losses. Loss per share was -0.02.

Revenue2.35M
Gross Profit 2.35M
Operating Income -7.07M
Pretax Income -7.37M
Net Income -7.37M
EBITDA -6.59M
EBIT -7.07M
Loss Per Share -0.02
Full Income Statement

Balance Sheet

The company has 1.59 million in cash and 6.92 million in debt, with a net cash position of -5.33 million or -0.01 per share.

Cash & Cash Equivalents 1.59M
Total Debt 6.92M
Net Cash -5.33M
Net Cash Per Share -0.01
Equity (Book Value) -826,193
Book Value Per Share -0.00
Working Capital 1.07M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.16 million and capital expenditures -458,986, giving a free cash flow of -6.62 million.

Operating Cash Flow -6.16M
Capital Expenditures -458,986
Depreciation & Amortization 479,294
Net Borrowing 4.66M
Free Cash Flow -6.62M
FCF Per Share -0.02
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -300.54%
Pretax Margin -313.39%
Profit Margin n/a
EBITDA Margin -280.16%
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ASX:BDX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.22%
Shareholder Yield -2.22%
Earnings Yield -28.56%
FCF Yield -25.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ASX:BDX has an Altman Z-Score of -6.77 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.77
Piotroski F-Score 2